MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model

被引:36
|
作者
Paiva, Isabel [1 ,2 ]
da Costa, Rui M. Gil [3 ,4 ]
Ribeiro, Joana [1 ,5 ]
Sousa, Hugo [1 ,5 ]
Bastos, Margarida M. S. M. [3 ]
Faustino-Rocha, Ana [7 ]
Lopes, Carlos [4 ]
Oliveira, Paula A. [6 ,7 ]
Medeiros, Rui [1 ,2 ,5 ,8 ,9 ]
机构
[1] Portuguese Inst Oncol Porto, Mol Oncol & Viral Pathol Grp, CI IPOP, P-4200072 Porto, Portugal
[2] Univ Porto, Abel Salazar Inst Biomed Sci, ICBAS, P-4050313 Porto, Portugal
[3] Univ Porto, Fac Engn, LEPABE, P-4200465 Porto, Portugal
[4] Portuguese Inst Oncol, CI IPOP, Expt Pathol & Therapeut Grp, P-4200072 Porto, Portugal
[5] Portuguese Inst Oncol Porto, Virol Serv, P-4200072 Porto, Portugal
[6] Univ Tras Os Montes & Alto Douro, UTAD, Dept Vet Sci, P-5001801 Vila Real, Portugal
[7] Univ Tras Os Montes & Alto Douro, UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, P-5001911 Vila Real, Portugal
[8] Fernando Pessoa Univ, Fac Hlth Sci, CEBIMED, Porto, Portugal
[9] Portuguese League Canc Liga Portuguesa Cancro Nuc, P-4200177 Porto, Portugal
关键词
K14-HPV16; miR-21; Microenvironment; In situ carcinoma; Hyperplasia; NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS INFECTION; CANCER; CARCINOMA; INFLAMMATION; MIR-21; NEOPLASIA; GRADE; GENE; HEAD;
D O I
10.1016/j.lfs.2015.02.020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: Human papillomaviruses (HPVs) are responsible for several types of cancer. K14-HPV16 transgenic mice express the HPV16 early genes, developing multi-step carcinogenesis associated with marked inflammation, as observed in human patients. MicroRNAs (MiRNA) constitute a class of non-coding RNAs that regulate gene expression. In particular, miR-21 has been associated with carcinogenesis. However, little is known about this microRNA in the normal tissue microenvironment and its possible relationship with cancer predisposition. We hypothesized that miR-21 expression influences each tissue's susceptibility to HPV-induced carcinogenesis. Main methods: In order to test this hypothesis, we evaluated miR-21 expression by RT-qPCR in ear and chest skin samples from 24-28 weeks old, female K14-HPV16 transgenic and wild-type mice. Key findings: In wild-type mice (HPV-/-) miR-21 expression was lower in ear skin compared with that of chest skin (p = 0.036). Under the influence of HPV16 oncogenes, transgenic animals (HPV16+/-), developed in situ carcinoma in all ear samples and epidermal hyperplasia in chest samples. These results are consistent with the hypothesis that microRNA expression in the microenvironment of normal tissues may influence HPV-associated carcinogenesis. Furthermore, among transgenic animals, miR-21 expression was lower in in situ carcinoma samples compared with hyperplasia (p = 0043). Significance: This suggests that, despite the well-known role of miR-21 as an oncogene, its anti-inflammatory and immunomodulatory properties may modulate HPV-induced carcinogenesis in a tissue-dependent manner. Further studies are warranted in order to explore the role of microRNAs in tissue susceptibility to carcinogenesis. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 28 条
  • [21] Diindolylmethane Inhibits Cervical Dysplasia, Alters Estrogen Metabolism, and Enhances Immune Response in the K14-HPV16 Transgenic Mouse Model
    Sepkovic, Daniel W.
    Stein, Johann
    Carlisle, Antoine D.
    Ksieski, H. Barbara
    Auborn, Karen
    Bradlow, H. Leon
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) : 2957 - 2964
  • [22] 3,3′-Diindolylmethane Increases Serum Interferon-γ Levels in the K14-HPV16 Transgenic Mouse Model for Cervical Cancer
    Sepkovic, Daniel W.
    Raucci, Laura
    Stein, Johann
    Carlisle, Antoine D.
    Auborn, Karen
    Ksieski, H. Barbara
    Nyirenda, Themba
    Bradlow, H. Leon
    IN VIVO, 2012, 26 (02): : 207 - 211
  • [23] Study on the antineoplastic and toxicological effects of pomegranate (Punica granatum L.) leaf infusion using the K14-HPV16 transgenic mouse model
    Yu, Manyou
    Gouvinhas, Irene
    Pires, Maria J.
    Neuparth, Maria J.
    da Costa, Rui M. Gil
    Medeiros, Rui
    Bastos, Margarida M. S. M.
    Vala, Helena
    Felix, Luis
    Venancio, Carlos
    Barros, Ana I. R. N. A.
    Oliveira, Paula A.
    FOOD AND CHEMICAL TOXICOLOGY, 2023, 174
  • [24] Magnetic Resonance Imaging Defines Cervicovaginal Anatomy, Cancer, and VEGF Trap Antiangiogenic Efficacy in Estrogen-Treated K14-HPV16 Transgenic Mice
    Garbow, Joel R.
    Santeford, Andrea C.
    Anderson, Jeff R.
    Engelbach, John A.
    Arbeit, Jeffrey M.
    CANCER RESEARCH, 2009, 69 (20) : 7945 - 7952
  • [25] Characterization of the Human Papillomavirus 16 Oncogenes in K14HPV16 Mice: Sublineage A1 Drives Multi-Organ Carcinogenesis
    Cochicho, Daniela
    Nunes, Alexandra
    Gomes, Joao Paulo
    Martins, Luis
    Cunha, Maerio
    Medeiros-Fonseca, Beatriz
    Oliveira, Paula
    Bastos, Margarida M. S. M.
    Medeiros, Rui
    Mendonca, Joana
    Vieira, Luis
    Gil da Costa, Rui M.
    Felix, Ana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [26] Results from a Dose-Response Study Using 3,3′-Diindolylmethane in the K14-HPV16 Transgenic Mouse Model: Cervical Histology
    Sepkovic, Daniel W.
    Stein, Johann
    Carlisle, Antoine D.
    Ksieski, H. Barbara
    Auborn, Karen
    Raucci, Laura
    Nyirenda, Themba
    Bradlow, H. Leon
    CANCER PREVENTION RESEARCH, 2011, 4 (06) : 890 - 896
  • [27] Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model
    Arvizu-Hernandez, Erandi
    Hernandez-Guerrero, Claudia Judith
    Alvarez-Rios, Elizabeth
    Gariglio, Patricio
    Cornejo-Garrido, Jorge
    Ocadiz-Delgado, Rodolfo
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [28] Diindolylmethane Inhibits Cervical Dysplasia, Alters Estrogen Metabolism, and Enhances Immune Response in the K14-HPV16 Transgenic Mouse Model (vol 18, pg 2957, 2009)
    Sepkovic, D. W.
    Stein, J.
    Carlisle, A. D.
    Ksieski, H. B.
    Auborn, K.
    Bradlow, H. L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) : 628 - 628